Ashcroft DM - Search Results

1

The incidence of psoriasis in Chile: an analysis of the National Waiting List Repository.

Lecaros C, Dunstan J, Villena F, Ashcroft DM, Parisi R, Griffiths CEM, Härtel S, Maul JT, De la Cruz C. Lecaros C, et al. Among authors: ashcroft dm. Clin Exp Dermatol. 2021 Oct;46(7):1262-1269. doi: 10.1111/ced.14713. Epub 2021 Jun 26. Clin Exp Dermatol. 2021. PMID: 33914930 Free PMC article.

2

Quality of life measures in psoriasis: a critical appraisal of their quality.

Ashcroft DM, Li Wan Po A, Williams HC, Griffiths CE. Ashcroft DM, et al. J Clin Pharm Ther. 1998 Oct;23(5):391-8. doi: 10.1046/j.1365-2710.1998.00181.x. J Clin Pharm Ther. 1998. PMID: 9875689 Review.

3

Clinical measures of disease severity and outcome in psoriasis: a critical appraisal of their quality.

Ashcroft DM, Wan Po AL, Williams HC, Griffiths CE. Ashcroft DM, et al. Br J Dermatol. 1999 Aug;141(2):185-91. doi: 10.1046/j.1365-2133.1999.02963.x. Br J Dermatol. 1999. PMID: 10468786 Review.

4

Systematic review of comparative efficacy and tolerability of calcipotriol in treating chronic plaque psoriasis.

Ashcroft DM, Po AL, Williams HC, Griffiths CE. Ashcroft DM, et al. BMJ. 2000 Apr 8;320(7240):963-7. doi: 10.1136/bmj.320.7240.963. BMJ. 2000. PMID: 10753146 Free PMC article. Review.

5

Therapeutic strategies for psoriasis.

Ashcroft DM, Li Wan Po A, Griffiths CE. Ashcroft DM, et al. J Clin Pharm Ther. 2000 Feb;25(1):1-10. doi: 10.1046/j.1365-2710.2000.00254.x. J Clin Pharm Ther. 2000. PMID: 10771459 Review.

6

Combination regimens of topical calcipotriene in chronic plaque psoriasis: systematic review of efficacy and tolerability.

Ashcroft DM, Li Wan Po A, Williams HC, Griffiths CE. Ashcroft DM, et al. Arch Dermatol. 2000 Dec;136(12):1536-43. doi: 10.1001/archderm.136.12.1536. Arch Dermatol. 2000. PMID: 11115167 Review.

7

Cost-effectiveness analysis of topical calcipotriol versus short-contact dithranol. In the treatment of mild to moderate plaque psoriasis.

Ashcroft DM, Li Wan Po A, Williams HC, Griffiths CE. Ashcroft DM, et al. Pharmacoeconomics. 2000 Nov;18(5):469-76. doi: 10.2165/00019053-200018050-00006. Pharmacoeconomics. 2000. PMID: 11151400

8

Optimal management of severe plaque form of psoriasis.

Fairhurst DA, Ashcroft DM, Griffiths CE. Fairhurst DA, et al. Among authors: ashcroft dm. Am J Clin Dermatol. 2005;6(5):283-94. doi: 10.2165/00128071-200506050-00002. Am J Clin Dermatol. 2005. PMID: 16252928 Review.

9

Trade-offs between the benefits and risks of drug treatment for psoriasis: a discrete choice experiment with U.K. dermatologists.

Ashcroft DM, Seston E, Griffiths CE. Ashcroft DM, et al. Br J Dermatol. 2006 Dec;155(6):1236-41. doi: 10.1111/j.1365-2133.2006.07535.x. Br J Dermatol. 2006. PMID: 17107395

10

Balancing the benefits and risks of drug treatment: a stated-preference, discrete choice experiment with patients with psoriasis.

Seston EM, Ashcroft DM, Griffiths CE. Seston EM, et al. Among authors: ashcroft dm. Arch Dermatol. 2007 Sep;143(9):1175-9. doi: 10.1001/archderm.143.9.1175. Arch Dermatol. 2007. PMID: 17875880

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

403 results

Search Page

Filters